Kiran Vemuri

5.1k total citations
70 papers, 2.7k citations indexed

About

Kiran Vemuri is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kiran Vemuri has authored 70 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pharmacology, 42 papers in Cellular and Molecular Neuroscience and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kiran Vemuri's work include Cannabis and Cannabinoid Research (61 papers), Neurotransmitter Receptor Influence on Behavior (35 papers) and Neuroscience and Neuropharmacology Research (19 papers). Kiran Vemuri is often cited by papers focused on Cannabis and Cannabinoid Research (61 papers), Neurotransmitter Receptor Influence on Behavior (35 papers) and Neuroscience and Neuropharmacology Research (19 papers). Kiran Vemuri collaborates with scholars based in United States, Canada and Saudi Arabia. Kiran Vemuri's co-authors include Alexandros Makriyannis, John D. Salamone, Ganesh A. Thakur, A. Makriyannis, Kelly S. Sink, George Kunos, Patrick A. Randall, Teresa Olszewska, David R. Janero and Douglas Osei‐Hyiaman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Kiran Vemuri

69 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kiran Vemuri United States	32	1.9k	1.4k	507	445	437	70	2.7k
Francisco Javier Pavón Spain	34	1.7k 0.9×	1.3k 0.9×	914 1.8×	662 1.5×	561 1.3×	147	4.0k
Darren Fegley United States	9	2.4k 1.3×	1.5k 1.1×	281 0.6×	346 0.8×	603 1.4×	10	2.8k
A. Makriyannis United States	24	1.6k 0.8×	1.2k 0.8×	387 0.8×	257 0.6×	367 0.8×	52	2.2k
Federico Massa France	21	1.4k 0.7×	884 0.6×	274 0.5×	315 0.7×	423 1.0×	29	2.2k
Felice Nava Italy	26	1.2k 0.6×	742 0.5×	380 0.7×	443 1.0×	315 0.7×	65	2.5k
Marnie Duncan United Kingdom	21	2.6k 1.4×	1.2k 0.9×	295 0.6×	418 0.9×	623 1.4×	23	3.0k
Susan M. Huang United States	15	1.5k 0.8×	925 0.6×	378 0.7×	576 1.3×	264 0.6×	18	2.3k
Basalingappa L. Hungund United States	33	2.0k 1.1×	1.8k 1.2×	541 1.1×	336 0.8×	302 0.7×	74	3.2k
C. S. Breivogel United States	22	2.5k 1.3×	2.0k 1.4×	498 1.0×	250 0.6×	549 1.3×	36	3.0k
Robert B. Laprairie Canada	24	2.1k 1.1×	1.2k 0.9×	598 1.2×	159 0.4×	355 0.8×	80	2.6k

Countries citing papers authored by Kiran Vemuri

Since Specialization

Citations

This map shows the geographic impact of Kiran Vemuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiran Vemuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiran Vemuri more than expected).

Fields of papers citing papers by Kiran Vemuri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiran Vemuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiran Vemuri. The network helps show where Kiran Vemuri may publish in the future.

Co-authorship network of co-authors of Kiran Vemuri

This figure shows the co-authorship network connecting the top 25 collaborators of Kiran Vemuri. A scholar is included among the top collaborators of Kiran Vemuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiran Vemuri. Kiran Vemuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hua, Tian, Kiran Vemuri, Spyros P. Nikas, et al.. (2025). Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature. 646(8085). 754–758. 1 indexed citations

Vemuri, Kiran, et al.. (2023). The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female mice. Psychopharmacology. 241(3). 427–443. 1 indexed citations

Vemuri, Kiran, Charlotte Thålin, Viktoria Hjalmar, et al.. (2023). PB0707 Neutrophil Extracellular Traps Promote Cancer-Associated Inflammation and Myocardial Stress. Research and Practice in Thrombosis and Haemostasis. 7. 101306–101306. 1 indexed citations

Eid, Basma G., Thikryat Neamatallah, Amina M. Bagher, et al.. (2023). Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats. SHILAP Revista de lepidopterología. 23(6). 1069–1078.

Cavin, Jean‐Baptiste, Catherine M. Keenan, Laurie E. Wallace, et al.. (2022). Role of CB₁ receptors in the acute regulation of small intestinal permeability: effects of high-fat diet. American Journal of Physiology-Gastrointestinal and Liver Physiology. 323(3). G219–G238. 10 indexed citations

Sachdev, Shivani, Kiran Vemuri, Samuel D. Banister, et al.. (2019). In vitro determination of the efficacy of illicit synthetic cannabinoids at CB ₁ receptors. British Journal of Pharmacology. 176(24). 4653–4665. 39 indexed citations

Kangas, Brian D., Kiran Vemuri, Shakiru O. Alapafuja, et al.. (2019). Cannabinoid Antagonist Drug Discrimination in Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics. 372(1). 119–127. 5 indexed citations

Laprairie, Robert B., Kiran Vemuri, Edward L. Stahl, et al.. (2019). Probing the CB1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist. Molecular Pharmacology. 96(5). 619–628. 4 indexed citations

Tyukhtenko, Sergiy, Ioannis Karageorgos, Nikolai Zvonok, et al.. (2018). Effects of Distal Mutations on the Structure, Dynamics and Catalysis of Human Monoacylglycerol Lipase. Scientific Reports. 8(1). 1719–1719. 29 indexed citations

10.

Limebeer, Cheryl L., et al.. (2017). CB₁ receptor antagonism in the bed nucleus of the stria terminalis interferes with affective opioid withdrawal in rats.. Behavioral Neuroscience. 131(4). 304–311. 12 indexed citations

11.

Barutta, Federica, Séréna Grimaldi, Roberto Gambino, et al.. (2017). Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy. Nephrology Dialysis Transplantation. 32(10). 1655–1665. 43 indexed citations

12.

McLaughlin, Peter, et al.. (2017). Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor. Psychopharmacology. 234(6). 1029–1043. 10 indexed citations

13.

Trigo, José, Foteini Delis, Katerina Antoniou, et al.. (2016). The CB₁Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability. The International Journal of Neuropsychopharmacology. 19(12). pyw068–pyw068. 55 indexed citations

14.

Bronova, Irina, Brett Smith, Bulent Aydogan, et al.. (2015). Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1. American Journal of Respiratory Cell and Molecular Biology. 53(4). 555–562. 30 indexed citations

15.

Bowles, Nicole, Ilia N. Karatsoreos, Xiaosong Li, et al.. (2014). A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome. Proceedings of the National Academy of Sciences. 112(1). 285–290. 78 indexed citations

16.

Vemuri, Kiran, et al.. (2014). CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats. Psychopharmacology. 231(22). 4291–4300. 23 indexed citations

17.

Guo, Zhixiong, R. Duclos, Kiran Vemuri, & Alexandros Makriyannis. (2010). The conformations of 17β-estradiol (E2) and 17α-estradiol as determined by solution NMR. Tetrahedron Letters. 51(27). 3465–3469. 21 indexed citations

18.

Storr, Martin, Mohammad Bashashati, Christina L. Hirota, et al.. (2010). Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice. Neurogastroenterology & Motility. 22(7). 787–e223. 46 indexed citations

19.

Sink, Kelly S., Kristen N. Segovia, Jacquelyn R. Sink, et al.. (2009). Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142. European Neuropsychopharmacology. 20(2). 112–122. 66 indexed citations

20.

Sink, Kelly S., Kiran Vemuri, JodiAnne T. Wood, Alexandros Makriyannis, & John D. Salamone. (2008). Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113. Pharmacology Biochemistry and Behavior. 91(3). 303–306. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact